GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (NAS:NTRB) » Definitions » EV-to-EBITDA

Nutriband (Nutriband) EV-to-EBITDA : -7.15 (As of May. 13, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Nutriband EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Nutriband's enterprise value is $36.61 Mil. Nutriband's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was $-5.12 Mil. Therefore, Nutriband's EV-to-EBITDA for today is -7.15.

The historical rank and industry rank for Nutriband's EV-to-EBITDA or its related term are showing as below:

NTRB' s EV-to-EBITDA Range Over the Past 10 Years
Min: -98.82   Med: -22.43   Max: -3.18
Current: -7.15

During the past 9 years, the highest EV-to-EBITDA of Nutriband was -3.18. The lowest was -98.82. And the median was -22.43.

NTRB's EV-to-EBITDA is ranked worse than
100% of 465 companies
in the Biotechnology industry
Industry Median: 9.34 vs NTRB: -7.15

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-13), Nutriband's stock price is $3.36. Nutriband's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was $-0.690. Therefore, Nutriband's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Nutriband EV-to-EBITDA Historical Data

The historical data trend for Nutriband's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband EV-to-EBITDA Chart

Nutriband Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -29.38 -46.03 -5.14 -6.46 -4.47

Nutriband Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.46 -5.59 -7.13 -3.77 -4.47

Competitive Comparison of Nutriband's EV-to-EBITDA

For the Biotechnology subindustry, Nutriband's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nutriband's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nutriband's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Nutriband's EV-to-EBITDA falls into.



Nutriband EV-to-EBITDA Calculation

Nutriband's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=36.607/-5.122
=-7.15

Nutriband's current Enterprise Value is $36.61 Mil.
Nutriband's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nutriband  (NAS:NTRB) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Nutriband's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=3.36/-0.690
=At Loss

Nutriband's share price for today is $3.36.
Nutriband's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.690.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Nutriband EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Nutriband's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband (Nutriband) Business Description

Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Executives
Michael Davidov director 60 EAST 42 STREET, NEW YORK NY 10165
Serguei Melnik director, 10 percent owner, officer: Chief Financial Officer
Gareth Sheridan director, 10 percent owner, officer: CEO 6064 CENTRAL COLLEGE RD., NEW ALBANY OH 43054
Vitalie Botgros director, 10 percent owner, officer: Chairman of the BOD GREGERSTR 36B, FISHAMEND C4 2401

Nutriband (Nutriband) Headlines